Prior studies have explored early biomarkers of COVID-19 co-infections including a 2021 multi-cohort study that reported an elevated baseline white blood cell count and stepwise decrease in CRP at two time points (admission and 48–72-h later) were sufficient to exclude COVID-19 bacterial co-infection in 46% of cases [27]. The gene discussed is CRP; the disease is COVID-19.